Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Ravuconazole is a new antifungal triazole with broad-spectrum activity and a long half-life in plasma. We studied the antifungal efficacy, safety, and pharmacokinetics of ravuconazole lysine phosphoester in escalating dosages for the treatment of invasive pulmonary aspergillosis due to Aspergillus f...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Petraitiene, Ruta, Petraitis, Vidmantas, Lyman, Caron A., Groll, Andreas H., Mickiene, Diana, Peter, Joanne, Bacher, John, Roussillon, Kristin, Hemmings, Melissa, Armstrong, Derrek, Avila, Nilo A., Walsh, Thomas J.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2004
Assuntos:
Experimental Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC375262/
https://ncbi.nlm.nih.gov/pubmed/15047519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.4.1188-1196.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares